Voriconazole for Horses: Uses, Dosing & Side Effects

This information is for educational purposes only. Never give your pet any medication without your veterinarian's guidance. Dosing, frequency, and safety depend on your pet's specific health profile.

Voriconazole is a prescription triazole antifungal medication. In horses, it is used extra-label, which means your vet may prescribe it even though it is not specifically FDA-approved for horses. That is common in equine medicine when a drug has useful evidence and there is no horse-labeled alternative.

This medication works by interfering with the fungal cell membrane. In practical terms, it helps slow or stop the growth of certain fungi that can be very difficult to treat. Voriconazole is especially important in equine eye care because it has good corneal penetration and activity against fungi commonly involved in equine keratomycosis, including Aspergillus and Fusarium.

Voriconazole may be used as an oral medication, an injectable medication in the hospital, or a compounded ophthalmic solution for the eye. The exact form depends on where the infection is located, how severe it is, and what your vet is trying to accomplish.

In horses, voriconazole is used most often for fungal eye infections, especially fungal keratitis or keratomycosis. Merck notes that topical voriconazole 1% has better corneal penetration than many other azoles and reaches therapeutic levels in the aqueous humor, which is one reason equine ophthalmologists may choose it for deep or stubborn corneal infections.

Your vet may also consider voriconazole for selected systemic fungal infections or as part of a broader antifungal plan when culture results, lesion location, or prior treatment response suggest it is a reasonable option. In some horses, it is combined with other therapies rather than used alone.

Because fungal disease can progress quickly, especially in the eye, treatment decisions are usually based on the horse's exam, corneal depth, culture or cytology results, and how practical frequent dosing will be for the pet parent and care team. A horse with a severe eye infection may need both medication and procedures such as a subpalpebral lavage system so treatment can be given often enough.

Always follow your vet's instructions exactly. Voriconazole dosing in horses is case-specific, and the right dose depends on whether the drug is being used topically in the eye, by mouth, or in the hospital by injection. Published equine pharmacokinetic work has evaluated oral dosing around 3 mg/kg to 4 mg/kg by mouth every 24 hours, but that does not mean every horse should receive that plan. Your vet may adjust the dose based on the infection site, formulation, response, and lab monitoring.

For equine fungal keratitis, Merck lists topical voriconazole 1% solution every 2 to 6 hours, with intensive therapy often starting every 2 to 4 hours before tapering. Horses commonly need treatment for at least 21 to 28 days, and many cases require longer care. Because that schedule is hard to maintain by hand, your vet may recommend a subpalpebral lavage to make treatment safer and more realistic.

Oral absorption in horses can be variable, and one equine study found better absorption with a powder formulation than with crushed tablets. That is one reason your vet may be very specific about the formulation, feeding instructions, and recheck schedule. Do not switch products, skip doses, or stop early without checking in, even if the eye or skin looks better.

Call your vet promptly if your horse develops loss of appetite, diarrhea, skin rash, hives, yellowing of the eyes or gums, weakness, trouble walking, or behavior changes while taking voriconazole. VCA notes that animal safety data are still limited, but concerns include gastrointestinal effects, liver problems, skin reactions, neurologic changes, vision problems, cardiovascular effects, and electrolyte abnormalities.

In an equine repeated-dose pharmacokinetic study, one horse developed an urticarial skin reaction, which suggests that hypersensitivity-type reactions can occur. Topical eye use may also cause local irritation in some horses, especially when the eye is already painful and inflamed.

Because voriconazole is metabolized by the liver and can have systemic effects, your vet may recommend bloodwork to monitor liver enzymes and electrolytes during treatment, especially for longer courses or oral use. See your vet immediately if your horse seems suddenly weak, develops marked swelling or hives, shows jaundice, or the eye becomes more painful, cloudy, or ruptures.

Voriconazole can interact with other medications because it affects cytochrome P450 liver enzymes. That means it may change how other drugs are broken down, and other drugs may also change voriconazole levels. Interaction risk is one reason your vet should review every prescription, supplement, and compounded product your horse receives.

Important caution areas include other drugs with liver effects, medications that may affect heart rhythm, and drugs that rely heavily on hepatic metabolism. In human prescribing information, voriconazole has many significant interactions, and while horse-specific data are limited, the same general caution applies in equine practice.

Tell your vet if your horse is receiving medications such as dexamethasone, omeprazole, clarithromycin, erythromycin, rifampin, phenylbutazone, flunixin meglumine, or other antifungals. Do not start or stop any medication during treatment unless your vet says it is safe.